Procalcitonin: Inflammatory Biomarker for Assessing the Severity of Community-Acquired Pneumonia - A Clinical Observation in Geriatric Patients
Bertsch T, Alber B, Esslinger AS, Dragonas C, Bauer JM, Sieber C, Heppner HJ (2010)
Publication Status: Published
Publication Type: Journal article
Publication year: 2010
Journal
Publisher: KARGER
Book Volume: 56
Pages Range: 385-389
Journal Issue: 4
DOI: 10.1159/000262285
Abstract
Community-acquired pneumonia is a common disease of the elderly and involves a high mortality risk. Demographic developments are creating new challenges for acute medical treatment strategies in geriatric patients with their underlying multimorbidity. In addition to the diagnostic parameters recorded on hospital admission, such as white cell count and C-reactive protein, procalcitonin, more than the risk scores CRB- and CURB-65 evaluated to date, appears to be a promising parameter for assessing the severity of pneumonia in elderly patients to allow early detection of severe courses and initiation of suitable treatment. The decisive factor is the dynamic course of the procalcitonin values over 3 consecutive days, as demonstrated in this case series. Copyright (C) 2009 S. Karger AG, Basel
Authors with CRIS profile
Adelheid Susanne Esslinger
Fachbereich Wirtschaftswissenschaften
Cornel Sieber
Lehrstuhl für Innere Medizin (Geriatrie)
Hans Jürgen Heppner
Involved external institutions
Germany (DE)How to cite
APA:
Bertsch, T., Alber, B., Esslinger, A.S., Dragonas, C., Bauer, J.M., Sieber, C., & Heppner, H.J. (2010). Procalcitonin: Inflammatory Biomarker for Assessing the Severity of Community-Acquired Pneumonia - A Clinical Observation in Geriatric Patients. Gerontology, 56(4), 385-389. https://dx.doi.org/10.1159/000262285
MLA:
Bertsch, T., et al. "Procalcitonin: Inflammatory Biomarker for Assessing the Severity of Community-Acquired Pneumonia - A Clinical Observation in Geriatric Patients." Gerontology 56.4 (2010): 385-389.
BibTeX: Download